Vir Biotechnology Inc
VIR
NASDAQ
Biotechnology
$9.24
USD
+0.24 (+2.67%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.50B
Volume 1.0M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
BCAX | Bicara Therapeutics Inc | $1.82B | - | - | - | |
XNCR | Xencor Inc | $1.70B | - | -33.2% | - | |
ABSI | Absci Corp | $1.62B | - | -61.9% | - | |
TRAX | First Tracks Biotherapeutics Inc | $1.54B | - | - | - | |
JBIO | Jade Biosciences Inc | $1.51B | - | - | - | |
VIR | Vir Biotechnology Inc | $1.50B | - | +1496.1% | - | |
TYRA | Tyra Biosciences Inc | $1.49B | - | - | - | |
AVBP | ArriVent BioPharma Inc | $1.44B | - | - | - | |
ORIC | Oric Pharmaceuticals Inc | $1.42B | - | - | - | |
GLUE | Monte Rosa Therapeutics Inc | $1.35B | - | -83.9% | - | |
AKTS | Aktis Oncology Inc | $1.33B | - | +49.9% | - |
Top Peer by Growth
Vir Biotechnology Inc
+1496.1% YoY Revenue
Best 1-Year Return
Monte Rosa Therapeutics Inc
+258.4% Return